Implant Stage 2 Uncovering Visit Template

Implant uncovering/second stage surgery.

RMH: Medical history reviewed/updates
Vitals: BP/pulse; other vitals if indicated

Implant site: #Tooth number(s)
Healing period since placement: Healing period since placement

Uncovering support: Implant placement date, implant system, site, and healing interval
Osseointegration/radiograph support: Clinical/radiographic confirmation
Healing abutment details: Type/size/torque and component records

Consent: Consent/PARQ reviewed; signed/verbally obtained

Anesthesia: Anesthetic used
Carps: Carpules/amount

Procedure:
Incision made over implant.
Cover screw exposed.
Cover screw removed.
Implant platform examined.
Osseointegration confirmed.
Healing abutment placed.
Healing abutment torqued.
Tissue adapted around abutment.
Sutured with: Suture material/size
Hemostasis achieved.

Complications: None or describe.

Patient tolerance: Tolerance/response.

Post-op instructions: Instructions reviewed.
Rx: Prescription or none

Allow healing before impression.

NV: Next visit

What documentation is required for Implant Uncovering?

Auditors reviewing an uncovering visit are checking (1) that the implant was placed under a 2-stage protocol so an uncovering is appropriate, (2) that osseointegration has occurred and the implant is ready to be exposed, (3) which implant system / platform / connection is in the mouth so future restorative parts can match, (4) what was actually placed at uncovering (healing abutment vs definitive abutment) and at what torque, and (5) the planned restorative pathway and timing.

A defensible chart note includes:

• Medical history reviewed and updated this visit — meds, conditions, allergies, anticoagulants (especially DOACs and warfarin given soft-tissue surgery), antiresorptives / bisphosphonates / denosumab (MRONJ risk for any soft-tissue manipulation around bone-anchored implants), immunosuppression, smoking status, glycemic control if diabetic. Document any change since D6010 placement, even if 'no changes.'
• Vitals (BP / pulse) at minimum — most state boards require vitals on adult therapeutic visits with anesthesia, and uncovering visits commonly use local infiltration.
• Implant site by tooth number (universal numbering). 'Implant #19' or 'implant in #30 site.'
• Implant placement date and surgical record reference — when the implant was placed (D6010 / D6011 / D6012 / D6013), under which protocol (1-stage non-submerged vs 2-stage submerged), and the elapsed osseointegration interval. Without an explicit placement date, an auditor cannot tell whether the integration interval was clinically reasonable.
• Implant system, line, platform, and connection type — manufacturer (Straumann, Nobel Biocare, Zimvie / Zimmer Biomet, BioHorizons, Dentsply Sirona / Astra / Ankylos, Neodent, Hiossen, MIS, Megagen, Implant Direct, etc.), implant line (e.g., Straumann BLT, Nobel Active, Astra EV, BioHorizons Tapered Internal), platform diameter / size designation (NP / RP / WP, NC / RC, 3.5 / 4.5 / 5.7 mm), and connection geometry (internal hex, external hex, conical / Morse-taper, tri-channel, tri-lobe). Without this, no future provider can match the right healing abutment, definitive abutment, or replacement screw.
• Healing interval since placement — explicit number of weeks or months from D6010 to today's uncovering. Typical: 3-4 months mandible, 4-6 months maxilla, longer with concurrent grafting / compromised bone / systemic risk.
• Confirmation of osseointegration / readiness to expose — radiographic stability (PA showing no peri-implant radiolucency, intact crestal bone, no thread exposure beyond placement baseline), absence of pain on percussion through soft tissue (where palpable), no fluctuance or tenderness over the implant site, healthy overlying mucosa, ISQ if a resonance-frequency device was used at placement and re-measured today, sounding tone if used. Letter of approval / clearance from the placing surgeon if surgery was done at a different office.
• Consent / PARQ reviewed and updated — the original D6010 consent covered placement. Uncovering consent should re-state: small soft-tissue procedure to expose the implant, possible need for crestal incision and suture vs simple punch, normal expected post-op (mild discomfort, possible minor bleeding, transient sensitivity around the healing abutment), unlikely but possible findings (peri-implantitis discovered at uncovery, soft-tissue insufficiency requiring graft, implant mobility requiring removal, thread exposure requiring corrective surgery), and the planned next steps. Signed written consent is best practice; verbal consent must be witnessed and dated.
• Anesthesia details — agent (typically 2% lidocaine 1:100,000 epinephrine or 4% articaine 1:100,000 epinephrine for posterior mandibular sites needing infiltration to bone over a thicker cortex), carpules administered, technique (local infiltration vs block), location, and patient response. Topical-only is acceptable for simple punch uncoveries on thin keratinized tissue.
• Pre-op radiograph (PA) — diagnostic-quality periapical at the implant site immediately before uncovering, confirming integration and locating the cover screw. Bills separately under D0220 (single PA) when exposed for this visit.
• Soft-tissue access technique — explicit description of the method used: tissue punch (state size, e.g., '4 mm circular blade tissue punch'), crestal incision (length, location, releases if any), or laser troughing (laser type and power, e.g., 'diode laser 1.0 W continuous'). Specify whether keratinized tissue was preserved on the buccal (important for long-term peri-implant health).
• Cover screw removal — confirmed retrieval, intact, archived in the patient's component log if the practice tracks it. Note any difficulty (stripped slot, granulation overgrowth, bone overgrowth requiring bone removal with a piezoelectric or surgical bur).
• Implant platform examination — clean, free of granulation / soft-tissue ingrowth / cement remnants, internal connection visualized, no platform damage, no thread exposure beyond placement baseline. Sulcus irrigated (chlorhexidine 0.12% or saline).
• Osseointegration confirmation at platform level — implant solid, no rotation when test-engaged with the driver / placement tool, no fluid expressed from sulcus on gentle pressure. PA showing intact crestal bone is the radiographic counterpart.
• Healing abutment placed — manufacturer / catalog number / lot, cuff (gingival) height in mm, diameter at platform and at coronal end (anatomical / straight-emergence / wider profile for molar emergence), seating verified clinically and (where indicated) radiographically. Cuff height is selected to be slightly above the soft-tissue level so the tissue heals around the abutment, not over it.
• Healing-abutment torque — most manufacturers specify hand-tight or finger-tight for healing abutments (typically 10-15 Ncm with a hand driver, not the 25-35 Ncm definitive-abutment torque). State the value applied and the manufacturer specification side by side. Many systems do not require a calibrated torque wrench for healing abutments; document accordingly.
• Soft tissue adapted around abutment — describe the resulting soft-tissue contour: keratinized tissue circumferentially, buccal band width, any soft-tissue redundancy that needed thinning, and whether the cuff height matches the tissue depth.
• Suturing if needed — material (typically 4-0 or 5-0 chromic gut, polyglactin / Vicryl, PTFE, or polypropylene), interrupted vs continuous, number of sutures, and location. Many simple punch uncoveries are sutureless.
• Hemostasis achieved — pressure, gauze, hemostatic agent if used. Note bleeding character (capillary vs minor vessel) and time to hemostasis.
• Complications — explicitly noted, even if 'none.' Common items to call out: cover screw stripped or irretrievable; soft-tissue overgrowth requiring laser / electrosurgery / blade revision; crestal bone overgrowth requiring bur removal to access cover screw; peri-implant bone loss visible on PA (early peri-implantitis); implant mobility on driver engagement (failed integration); soft-tissue insufficiency requiring deferred graft.
• Patient tolerance and response — anesthesia adequacy, esthetic / functional reaffirmation, post-op instruction comprehension. Note any concerns and how they were addressed.
• Post-op instructions — soft diet 24-48 hours, avoid mechanical trauma to the healing abutment, salt-water rinses starting 24 hours post-op, soft-bristle brushing around the healing abutment with care, avoid Waterpik directly on the site for 1-2 weeks, what symptoms to report (significant swelling, throbbing pain, fever, pus, abutment loosening or falling out, suture loss before 7-10 days). Provide written instructions when possible.
• Rx if any — most uncoveries do not require antibiotics or narcotics. Some practices prescribe 0.12% chlorhexidine rinse for 7-10 days; ibuprofen 600 mg PRN typically sufficient for analgesia. Document Rx or 'none.'
• Healing interval before impression / restorative phase — explicit interval planned (typically 2-6 weeks for soft-tissue maturation before D6056 / D6057 abutment placement), and the planned next visit type and approximate date. Some clinicians wait longer (8-12 weeks) for esthetic anterior cases to allow papilla maturation.
• Restorative pathway documented — abutment-supported crown plan (D6056 or D6057 + D6058-D6064) vs implant-supported crown plan (D6065-D6067 with no separate abutment code), and the restorative dentist if not the same provider. Coordination note sent to restorative dentist if applicable.

The 'amnesia test' applies: a third party reading the chart must be able to identify which implant system / platform / connection is in the mouth, which healing abutment was placed (catalog and cuff height), how the soft tissue was accessed and managed, whether osseointegration was confirmed, and what the restorative plan and timing are. Generic 'cover screw out, healing abutment placed' without system, cuff height, integration confirmation, or restorative plan is the most common audit weakness on uncovering charts billed as D6011.

Why does Implant Uncovering get denied?

The most common reasons the uncovering visit (D6011) is denied, downgraded, or recouped:

• Missing-tooth clause exclusion — by far the most common cause of D6011 denial across PPO plans. The tooth at the implant site was extracted before the patient's coverage began, and the plan excludes the entire implant restoration including the second-stage surgery. Verify extraction date in eligibility before submitting.
• D6011 billed on a 1-stage (non-submerged) implant — coding error; if a healing abutment was placed at the original D6010 surgery, there is no second-stage exposure to bill. The carrier sees the original surgical record (or D6010 narrative) showing 1-stage protocol and denies D6011.
• Implant system / platform not documented — claim and chart don't identify which implant system and connection are in the mouth, so the carrier questions whether the healing abutment is system-appropriate. Most-cited weakness on uncovering audits.
• Osseointegration / readiness not documented — chart doesn't establish that the implant was integrated and ready to expose at the time of uncovering (no PA, no clinical readiness note, no elapsed-time confirmation). On premature-uncovery cases (<2 months in mandible, <3 months in maxilla without immediate-load justification), this is a recoup risk.
• D6011 billed on the same date as D6010 — coding-sequence error; the codes describe different surgical stages. Submitting both on the same date typically results in D6011 being denied as not separately billable. The exception is documented immediate-load protocols, but those are uncommon and usually not coded D6011 anyway.
• Healing abutment billed separately as D6056 — coding error; healing abutments are inclusive of D6011 (and inclusive of D6010 / D6011 / D6012 / D6013 generally) and not billable as D6056. A claim for D6011 + D6056 on the same date is often pulled for review and the D6056 line is denied.
• D6011 billed at the surgical placement (D6010) date — the second-stage code reported on the original surgery date; carrier denies because the second stage hasn't occurred yet.
• No PA on file at the uncovering date — some carriers require a peri-apical at the uncovering visit (or a recent PA from the case) to confirm the implant is present and integrated. Missing PA = documentation denial.
• Prior authorization not obtained on a plan that requires it — many plans require pre-auth for the entire implant case (D6010 + D6011 + abutment + crown). Missing pre-auth on the implant case = procedural denial that cascades to D6011.
• D6011 billed without a planned restoration — claim records show D6011 alone with no abutment / crown coded within the case timeline; some carriers question whether a restoration is actually planned and downgrade or hold.
• Pattern-matched templating across multiple cases — every D6011 chart in the practice reads identically with the same cuff height, the same '4 mm tissue punch,' the same 'no complications.' Auditors flag pattern-matched templates.
• Submitting D6011 with no implant placement record on file — when the original D6010 was performed at a different office and records were not requested, the carrier may have no claim history showing the implant was placed and deny D6011 as orphaned. Request and submit the placing surgeon's operative note when the original placement was external.
• Healing-abutment torque exceeds manufacturer specification — uncommon as a denial reason, but in audited fracture / loosening cases the chart's torque value (or absence of one) is reviewed. Healing abutments are typically hand-tight or 10-15 Ncm; do not torque to definitive-abutment values.
• Recoupment for 'inclusive of D6010' — some carriers' policies specifically state that uncovering is not separately reimbursable and bundle the entire submerged-protocol case under D6010. Less common on contemporary PPO plans, but appears in some legacy contracts and Medicaid MCOs.

What do practices ask about Implant Uncovering?

Which templates are related to Implant Uncovering?